Lantheus to Present at Upcoming Investor Conferences

Q: How long will it take to read this news story?

The story "Lantheus to Present at Upcoming Investor Conferences" has 153 words across 6 sentences, which will take approximately 1 - 2 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Lantheus to Present at Upcoming Investor Conferences" was covered 1 days ago by GlobeNewswire, a news publisher based in China.

Q: How trustworthy is 'GlobeNewswire' news outlet?

GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly technology news. The outlet is headquartered in China and publishes an average of 8 news stories per day. It's most recent story was published 17 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #26318565</li><li>URL: https://beamstart.com/news/lantheus-to-present-at-upcoming-17401447332175</li></ul>

GlobeNewswire 1d ago

Lantheus to Present at Upcoming Investor Conferences - GlobeNewswire

Quick Summary:

Riley Securities Precision Oncology & Radiopharma Day in New York on February 28TD Cowen 45th Annual Health Care Conference in Boston on March 4 at 2:30 pm ETLeerink Global Healthcare Conference 2025 in Miami on March 11 at 1:40 pm ET A live webcast will be available for the TD Cowen 45th Annual Health Care Conference and Leerink Global Healthcare Conference presentations on the Investors section of the Company’s website at A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentations.

BEDFORD, Mass., Feb.21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc.("Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its management team will present at the following upcoming investor conferences.B.

About Lantheus Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes.